Form 4: System1, Inc. Grants Stock Appreciation Rights to Chief Product Officer Brian Coppola
SEC Form 4
System1, Inc. granted Brian Coppola, Chief Product Officer, 475,000 stock appreciation rights (SARs) on July 1, 2024, under the 2024 Stock Appreciation Rights Plan.
Summary
- Brian Coppola, Chief Product Officer of System1, Inc., was granted 475,000 stock appreciation rights (SARs) on July 1, 2024.
- The SARs were granted under the System1, Inc. 2024 Stock Appreciation Rights Plan, as amended.
- The exercise price of the SARs is $1.44, which was the Issuer's closing price on the grant date.
- Upon exercise, Coppola will receive either Class A Common Stock or cash, at the Issuer's discretion.
- The amount will be equal to the number of shares underlying the SARs multiplied by the excess of the fair market value of one share of Class A Common Stock on the exercise date over $1.44.
- The SARs vest in four tranches based on System1, Inc. achieving trailing twelve month Adjusted EBITDA (TTM Adjusted EBITDA) targets: $50.0 million, $60.0 million, $70.0 million, and $80.0 million after the grant date, with 25% vesting upon achieving each target.
Sentiment
Score: 7
Explanation: The document is neutral to positive. It describes a standard executive compensation practice designed to incentivize performance. The vesting conditions based on Adjusted EBITDA targets suggest a focus on growth and profitability.
Positives
- The grant of SARs aligns the executive's interests with the company's performance, incentivizing growth in Adjusted EBITDA.
- The vesting schedule based on Adjusted EBITDA targets provides clear, measurable goals for the executive.
Risks
- The value of the SARs is dependent on System1, Inc.'s stock price exceeding $1.44 and the company achieving the Adjusted EBITDA targets.
- If the company does not meet the Adjusted EBITDA targets, a portion or all of the SARs may not vest.
Future Outlook
The vesting of the SARs is contingent upon System1, Inc. achieving specific Adjusted EBITDA targets, indicating a focus on improving financial performance.
Industry Context
Granting stock appreciation rights is a common practice to align executive compensation with company performance, particularly in growth-oriented companies. The use of Adjusted EBITDA as a vesting condition is also common, as it is a key metric for assessing profitability.
Comparison to Industry Standards
- Many companies use stock options or restricted stock units (RSUs) with similar vesting schedules tied to performance metrics.
- The specific Adjusted EBITDA targets would need to be compared to System1, Inc.'s historical performance and industry benchmarks to assess their difficulty.
- Companies like Trade Desk and PubMatic also use equity compensation extensively, but the specific terms vary based on company size, growth stage, and industry.
Stakeholder Impact
- Shareholders: The SARs grant is intended to align management's interests with shareholder value creation.
- Employees: The grant may have a positive impact on employee morale by demonstrating a commitment to rewarding key personnel.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Date of grant of Stock Appreciation Rights (SARs) |
| 07/01/2031 | Expiration date of the Stock Appreciation Rights (SARs) |
| 07/03/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.